Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-054093

10% owner sold 44,358 shares at an average $29.24 ($1,296,884)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
UBS Oncology Impact Fund L.P. 10% owner 2021-08-27 Sale −13,357 $29.09 $388,555 7,792,126 D: show line 1 in the form
UBS Oncology Impact Fund L.P. 10% owner 2021-08-30 Sale −31,001 $29.30 $908,329 7,761,125 D: show line 2 in the form
Open-market sales · 44,358 sh · avg $29.24 · $1,296,884
Loading xslF345X03/doc4.xml…